Kestra insider adds 942 shares via ESPP

Kestra Medical Technologies director and officer Traci S. Umberger acquired 942 shares of common stock through the company’s Employee Stock Purchase Plan.

Rhea-AI Filing Summary

Kestra Medical Technologies director and officer Traci S. Umberger acquired 942 shares of common stock through the company’s Employee Stock Purchase Plan. The shares were purchased for $21.55 per share, equal to 85% of the closing price on June 29, 2026, under a plan exempt under Rule 16b-3.

Following this ESPP purchase for the period from January 1, 2026 through June 30, 2026, Umberger beneficially owns 162,802 shares of Kestra common stock, which the filing notes includes unvested restricted stock units (RSUs).

Insider Trade Summary

Grant/Award: 942 shares

Grant/Award 1 txn

Insider Umberger Traci S

Role See Remarks

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	942	$21.55	$20K

Holdings After Transaction: Common Stock — 162,802 shares (Direct)

Footnotes (3)

1. F1. Shares purchased pursuant to the Kestra Medical Technologies, Ltd. 2025 Employee Stock Purchase Plan ("ESPP") in transactions that were exempt under Rule 16b-3, for the ESPP purchase period of January 1, 2026 through June 30, 2026.
2. F2. In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on June 29, 2026.
3. F3. Includes unvested RSUs.

Key Figures

ESPP shares acquired: 942 shares ESPP purchase price: $21.55 per share Beneficial ownership after transaction: 162,802 shares +2 more

5 metrics

ESPP shares acquired 942 shares Common stock acquired under ESPP for period Jan 1–Jun 30, 2026

ESPP purchase price $21.55 per share Equal to 85% of closing price on June 29, 2026

Beneficial ownership after transaction 162,802 shares Total Kestra common shares owned after ESPP purchase, includes unvested RSUs

Discount to market under ESPP 85% of closing price ESPP terms use 85% of June 29, 2026 closing price for purchase

ESPP period covered January 1–June 30, 2026 ESPP purchase period referenced in the Form 4 footnote

Key Terms

Employee Stock Purchase Plan, Rule 16b-3, ESPP, unvested RSUs

4 terms

Employee Stock Purchase Plan financial

"Shares purchased pursuant to the Kestra Medical Technologies, Ltd. 2025 Employee Stock Purchase Plan ("ESPP")"

An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.

Rule 16b-3 regulatory

"pursuant to the Kestra Medical Technologies, Ltd. 2025 Employee Stock Purchase Plan ("ESPP") in transactions that were exempt under Rule 16b-3"

Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.

ESPP financial

"In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price"

An Employee Stock Purchase Plan (ESPP) is a company program that lets employees buy the company’s shares at a reduced price, usually by setting aside a small portion of their pay over time. It matters to investors because it encourages employees to own part of the business—like giving staff a discounted membership— which can boost commitment and performance, while also potentially increasing the number of shares available and affecting shareholder value.

unvested RSUs financial

"Includes unvested RSUs."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Kestra Medical Technologies (KMTS) insider Traci S. Umberger do in this Form 4?

Traci S. Umberger acquired 942 shares of Kestra Medical Technologies common stock through the company’s Employee Stock Purchase Plan. The filing classifies this as a grant or award-type acquisition exempt under Rule 16b-3, not an open-market trade.

At what price were the new KMTS shares acquired under the ESPP?

The 942 Kestra Medical Technologies shares were acquired at $21.55 per share. Footnotes explain this represents 85% of the issuer’s common stock closing price on June 29, 2026, consistent with the terms of the Employee Stock Purchase Plan.

How many KMTS shares does Traci S. Umberger own after this ESPP transaction?

After the ESPP acquisition, Traci S. Umberger beneficially owns 162,802 shares of Kestra Medical Technologies common stock. The filing specifies that this figure includes unvested restricted stock units (RSUs) in addition to already vested or previously held shares.

What period does the Kestra Medical Technologies ESPP purchase cover in this Form 4?

The Employee Stock Purchase Plan transaction covers the purchase period from January 1, 2026 through June 30, 2026. The 942 shares reported in the Form 4 represent the total shares purchased for Traci S. Umberger during this specific ESPP offering period.

Is the KMTS insider acquisition in this Form 4 an open-market buy?

No, the Kestra Medical Technologies transaction is not an open-market buy. The filing states the shares were purchased under the company’s Employee Stock Purchase Plan and were exempt under Rule 16b-3, characterizing it as a plan-based, compensation-related acquisition.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/02/2026 - 05:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Umberger Traci S

(Last) (First) (Middle)

3933 LAKE WASHINGTON BLVD NE, SUITE 200

(Street)

KIRKLAND WASHINGTON 98033

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
KESTRA MEDICAL TECHNOLOGIES, LTD. [ KMTS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/30/2026	06/30/2026	A(1)		942	A	$21.55(2)	162,802(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares purchased pursuant to the Kestra Medical Technologies, Ltd. 2025 Employee Stock Purchase Plan ("ESPP") in transactions that were exempt under Rule 16b-3, for the ESPP purchase period of January 1, 2026 through June 30, 2026.

2. In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on June 29, 2026.

3. Includes unvested RSUs.

Remarks:

General Counsel and Chief Administrative Officer

	/s/ Traci S. Umberger	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)